These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 3136193

  • 1. Administration of an aldose reductase inhibitor induces a decrease of collagen fluorescence in diabetic rats.
    Suárez G, Rajaram R, Bhuyan KC, Oronsky AL, Goidl JA.
    J Clin Invest; 1988 Aug; 82(2):624-7. PubMed ID: 3136193
    [Abstract] [Full Text] [Related]

  • 2. Increased nerve polyol levels in experimental diabetes and their reversal by Sorbinil.
    Whiting PH, Ross IS.
    Br J Exp Pathol; 1988 Oct; 69(5):697-702. PubMed ID: 3143396
    [Abstract] [Full Text] [Related]

  • 3. Effects of aldose reductase inhibitor (M79175) on ERG oscillatory potential abnormalities in streptozotocin fructose-induced diabetes in rats.
    Funada M, Okamoto I, Fujinaga Y, Yamana T.
    Jpn J Ophthalmol; 1987 Oct; 31(2):305-14. PubMed ID: 3118085
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of the effect of aldose reductase inhibition on increased basement membrane collagen fluorescence in diabetic rats.
    Cohen MP, Klepser H, Wu VY.
    Gen Pharmacol; 1991 Oct; 22(4):603-6. PubMed ID: 1936894
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Diabetic complications in lens and nerve and their prevention by sulindac or sorbinil: two novel aldose reductase inhibitors.
    Jacobson M, Sharma YR, Cotlier E, Hollander JD.
    Invest Ophthalmol Vis Sci; 1983 Oct; 24(10):1426-9. PubMed ID: 6413448
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Diabetic neuropathy: treatment trial with an aldose reductase inhibitor (Sorbinil)].
    Christensen JE, Larsen AB, Gregersen G.
    Ugeskr Laeger; 1987 Nov 09; 149(46):3111-4. PubMed ID: 3127975
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Effects of M79175, an aldose reductase inhibitor, on experimental sugar cataracts].
    Ono H, Nozawa Y, Hayano S.
    Nippon Ganka Gakkai Zasshi; 1982 Nov 09; 86(9):1343-50. PubMed ID: 6818854
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Altering the course of cataracts in diabetic rats.
    Fukushi S, Merola LO, Kinoshita JH.
    Invest Ophthalmol Vis Sci; 1980 Mar 09; 19(3):313-5. PubMed ID: 6766909
    [Abstract] [Full Text] [Related]

  • 14. [Prevention of experimental diabetic corneal endotheliopathy with aldose reductase inhibitor].
    Akagi Y, Takahashi Y, Tanabe T, Ikebe H, Majima K, Miyatani H, Miyamoto Y, Terubayashi H.
    Nippon Ganka Gakkai Zasshi; 1987 Feb 09; 91(2):187-93. PubMed ID: 3111199
    [No Abstract] [Full Text] [Related]

  • 15. Raman spectroscopic study of the effect of aldose reductase inhibitor on experimental diabetic cataract.
    Nozawa H, Yaginuma T, Mizuno A.
    Nippon Ganka Gakkai Zasshi; 1988 Jan 09; 92(1):194-201. PubMed ID: 3133929
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effect of aldose reductase inhibitor (sorbinil) on integration of polyol pathway, pentose phosphate pathway, and glycolytic route in diabetic rat lens.
    Gonzalez AM, Sochor M, Hothersall JS, McLean P.
    Diabetes; 1986 Nov 09; 35(11):1200-5. PubMed ID: 3093302
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.